Kimberly Jo Fritz, APSW in Rhinelander, WI - Case Manager/Care Coordinator

Kimberly Jo Fritz, APSW is a Case Manager/care Coordinator based in Rhinelander, Wisconsin. Kimberly Jo Fritz is licensed to practice in Wisconsin (license number ) and her current practice location is 705 E Timber Dr, Rhinelander, Wisconsin. She can be reached at her office (for appointments etc.) via phone at (715) 369-2215.

NPI number for Kimberly Jo Fritz is 1770265282 and her current mailing address is 705 E Timber Dr, Rhinelander, Wisconsin. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1770265282.

Contact Information

	Kimberly Jo Fritz, APSW
	705 E Timber Dr, Rhinelander, WI 54501-2859
	(715) 369-2215
	Not Available

Healthcare Provider's Profile

Full Name	Kimberly Jo Fritz
Gender	Female
Speciality	Case Manager/care Coordinator
Location	705 E Timber Dr, Rhinelander, Wisconsin
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1770265282
Provider Enumeration Date: 08/03/2023
Last Update Date: 03/14/2024

Medical Identifiers

Medical identifiers for Kimberly Jo Fritz such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1770265282	NPI	-	NPPES
100268845	Medicaid	WI
251S00000X	Other	WI	CRISIS INTERVENTION TECHNOLOGY

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
1041C0700X	Social Worker - Clinical	132410 (Wisconsin)	Secondary
171M00000X	Case Manager/care Coordinator	(Wisconsin)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Kimberly Jo Fritz is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Kimberly Jo Fritz, APSW 705 E Timber Dr, Rhinelander, WI 54501-2859 Ph: (715) 369-2215	Kimberly Jo Fritz, APSW 705 E Timber Dr, Rhinelander, WI 54501-2859 Ph: (715) 369-2215

News Archive

CytRx announces its plans to advance multiple oncology development programs in 2010

CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced its plans for 2010 aimed at advancing the clinical development of its high-value drug development pipeline and enhancing shareholder value.

Research may lead to better treatments for depression and substance abuse

In what has been hailed as a breakthrough, scientists from Columbia University Medical Center and Weill Cornell Medical College have outlined the molecular mechanism of membrane transport. The research shows how a protein transforms its shape to transport substances across the cell membrane in order to regulate transmission of the brain's messages across the synaptic gap from one neuron to another.

Children living in non-redeveloped public housing more likely to take repeated trips to emergency rooms

San Francisco children living in non-redeveloped public housing are 39 percent more likely to repeatedly visit emergency rooms, according to new research from UC San Francisco and UC Berkeley.

Researchers are testing wearable devices to detect early Alzheimer's, other neurodegenerative diseases

The development of a wearable to detect early Alzheimer's and other neurodegenerative diseases years before symptoms show has taken a step closer to reality today, as UK charity Alzheimer's Research UK announces a partnership with Boston University that will see the first digital data flowing into its global Early Detection of Neurodegenerative diseases (EDoN) initiative.

ADDF provides $248,000 grant to ALSP to allow its lead drug candidate towards clinical trials

The Alzheimer's Drug Discovery Foundation announced today that it is providing a grant of $248,000 to American Life Science Pharmaceuticals, Inc. to allow for manufacture of its lead drug candidate to be used in preclinical toxicology testing in preparation for entering Phase I clinical trials early in 2011.

Kimberly Jo Fritz, APSW - in Rhinelander, WI